TY  - JOUR
AU  - Kasi, Phanindra Babu
AU  - Mallela, Venkata Ramana
AU  - Ambrozkiewicz, Filip
AU  - Trailin, Andriy
AU  - Liška, Václav
AU  - Hemminki, Kari
TI  - Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
JO  - International journal of molecular sciences
VL  - 24
IS  - 9
SN  - 1422-0067
CY  - Basel
PB  - Molecular Diversity Preservation International
M1  - DKFZ-2023-00973
SP  - 7922
PY  - 2023
N1  - #LA:C020#
AB  - Colorectal cancer (CRC) is the third most common cancer worldwide, and metastatic CRC is a fatal disease. The CRC-affected tissues show several molecular markers that could be used as a fresh strategy to create newer methods of treating the condition. The liver and the peritoneum are where metastasis occurs most frequently. Once the tumor has metastasized to the liver, peritoneal carcinomatosis is frequently regarded as the disease's final stage. However, nearly 50
KW  - Humans
KW  - Nanomedicine: methods
KW  - Peritoneal Neoplasms
KW  - Precision Medicine
KW  - Nanotubes, Carbon
KW  - Gold
KW  - Metal Nanoparticles
KW  - Nanoparticles: therapeutic use
KW  - Colorectal Neoplasms: diagnosis
KW  - Colorectal Neoplasms: drug therapy
KW  - Theranostic Nanomedicine
KW  - Drug Delivery Systems: methods
KW  - cancer therapy (Other)
KW  - clinical status (Other)
KW  - colorectal cancer (Other)
KW  - nanomedicine (Other)
KW  - theranostics (Other)
KW  - Nanotubes, Carbon (NLM Chemicals)
KW  - Gold (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:37175627
C2  - pmc:PMC10178331
DO  - DOI:10.3390/ijms24097922
UR  - https://inrepo02.dkfz.de/record/276067
ER  -